Inuvo to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8th-10th LITTLE ROCK, Ark., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, announced today that it will be participating in the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025 at the Lotte New York Palace Hotel in New York City. Management is scheduled to present on Monday, September 8, 2025 at 11:30 AM Eastern Time. The presentation will be webcast live on the conferen...
A director at Collegium Pharmaceutical Inc sold 17,478 shares at 38.424USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
LeMaitre to Participate at Upcoming Investor Conferences in September BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in four upcoming investor conferences. 2025 Wells Fargo Healthcare Conference Wednesday, September 3, 2025 Encore Boston Harbor, Everett, MA Dorian LeBlanc, CFO, will present at 1:30 PM ET Cantor Global Healthcare Conference Thursday, September 4, 2025 InterContinental New York Barclay Hotel, New York, NY Dorian LeBlanc, CFO, will present at 10:55 AM ET Morgan Stanley 23rd ...
Collegium to Participate in Upcoming Investor Conferences STOUGHTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: 2025 Wells Fargo Healthcare ConferenceThursday, September 4, 2025Boston, MA Morgan Stanley 23rd Annual Global Healthcare ConferenceFireside Chat Date and Time: Monday, September 8, 2025 at 2:35 p.m. ETNew York, NY A live webcast of the fireside chat will be available via the Investors section of the Company's website: . A replay of the webcast will be archived on the Comp...
Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting STOUGHTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COLL) today announced it will present nine posters showcasing real-world data from its differentiated pain portfolio at PAINWeek 2025, taking place in Las Vegas, NV, September 2-5, 2025. The posters will highlight real-world data from the company’s portfolio of pain treatments and reflect Collegium’s continued commitment to responsible pain management. “We are pleased to present this new research to the pain care community,” said Thomas Smith, M....
A director at Opko Health Inc bought 675,000 shares at 1.320USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Inuvo Posts 25% Growth in the Second Quarter 2025 Management to host conference call at 4:15 PM ET, Thursday, August 7, 2025 LITTLE ROCK, Ark., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, today announced its financial results for the second quarter and six-month period ended June 30, 2025. Second Quarter 2025 Highlights Compared to Second Quarter 2024: Net revenue increased 25% to $22.7 million from $18.2 millionGross profit increased 12% to $17.1 millionAdjusted EBITDA improve...
Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook – Generated Record Quarterly Net Revenue of $188.0 Million, Up 29% Year-over-Year – – Generated Record Quarterly Jornay PM® Net Revenue of $32.6 Million and Grew Prescriptions by 23% Year-over-Year – – Generated Net Revenue of $155.4 Million from the Pain Portfolio, Up 7% Year-over-Year with All Three Core Products Recording Revenue Growth in the Quarter – – Raised Full-Year 2025 Net Revenue Guidance to be in the Range of $745 to $760 Million and Adjusted EBITDA Guidance in the Range of $440 to...
Angi Inc. Earnings Release and Letter to Shareholders Available on Company’s Website DENVER, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Angi Inc. (NASDAQ: ANGI) posted its second quarter financial results and a letter to shareholders from CEO, Jeffrey Kip on the investor relations section of its website at ir.angi.com/quarterly-earnings. As announced previously, Angi Inc. will host a conference call to discuss the company’s second quarter results and to answer questions. The call will be held on Wednesday, August 6, 2025, at 8:30 a.m. ET. Jeffrey Kip, CEO and Andrew Russakoff, CFO will participate...
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2025. Highlights from the second quarter of 2025 and recent weeks include the following: Merck advanced Phase 1 Epstein-Barr virus vaccine trial (). This investigational vaccine candidate is being developed in collaboration with Merck and evaluates safety and tolerability in up to 200 h...
Inuvo to Host Second Quarter 2025 Financial Results Conference Call on Thursday, August 7th at 4:15 P.M. ET LITTLE ROCK, Ark., July 31, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, will host a conference call on Thursday, August 7, 2025, at 4:15 PM Eastern Time to discuss its financial results and provide a business update for the second quarter ended June 30, 2025. Conference Call Details: Date: Thursday, August 7, 2025Time: 4:15 p.m. Eastern Time Toll-free Dial-in Number: 1-800-717-1738International Dial-in ...
OPKO Health to Report Second Quarter 2025 Financial Results on July 31 MIAMI, July 24, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Thursday, July 31, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on July 31 beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-re...
Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 STOUGHTON, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COLL) today announced that it will report second quarter 2025 financial results before the market opens on Thursday, August 7, 2025. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET. Conference Call Information To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q2 2025 Earnings Call.” An audio webc...
Angi Inc. to Announce Q2 2025 Earnings on August 5th and Host Earnings Conference Call on August 6th DENVER, July 16, 2025 (GLOBE NEWSWIRE) -- After the close of market trading on Tuesday, August 5, 2025, Angi Inc. (NASDAQ: ANGI) will post its second quarter results and simultaneously CEO Jeff Kip will publish a letter to shareholders, which may include certain forward-looking information, at ir.angi.com/quarterly-earnings. On Wednesday, August 6, 2025, at 8:30 a.m. ET, Angi Inc. will host a conference call to answer questions regarding the company’s second quarter results. The live audi...
LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025 BURLINGTON, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the live call....
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress MIAMI and JERUSALEM, July 08, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (“OPKO”) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that their abstract “First-in-Class Oral GLP-2 Analog for Treatment of Short Bowel Syndrome” has been selected for a poster presentation at the 47th European Society for Clinical Nutrition & Metabolism (“ESPEN”) Congress, taking place September 13–16, 2025, in Prague, Czech Republic. A...
Collegium Announces $150 Million Share Repurchase Program STOUGHTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced its Board of Directors has authorized a new share repurchase program to repurchase up to $150 million in common stock through December 31, 2026. This program replaces a previous $150 million share repurchase program authorized in January 2024 which expired on June 30, 2025, and had $65 million remaining under the progr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.